BRAIN Biotech Dividends and Buybacks
Dividend criteria checks 0/6
BRAIN Biotech does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Further Upside For BRAIN Biotech AG (ETR:BNN) Shares Could Introduce Price Risks After 27% Bounce
Nov 12
Further Upside For BRAIN Biotech AG (ETR:BNN) Shares Could Introduce Price Risks After 50% Bounce
Sep 24BRAIN Biotech AG (ETR:BNN) Screens Well But There Might Be A Catch
Aug 06Is BRAIN Biotech (ETR:BNN) Weighed On By Its Debt Load?
Jun 29BRAIN Biotech AG (ETR:BNN) Shares Could Be 36% Below Their Intrinsic Value Estimate
Apr 19BRAIN Biotech AG's (ETR:BNN) P/S Still Appears To Be Reasonable
Mar 28Is BRAIN Biotech (ETR:BNN) A Risky Investment?
Feb 16Here's Why BRAIN Biotech (ETR:BNN) Can Afford Some Debt
Sep 13Here's What B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shareholder Ownership Structure Looks Like
Mar 21Is B.R.A.I.N. Biotechnology Research and Information Network (ETR:BNN) Weighed On By Its Debt Load?
Feb 14When Will B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) Breakeven?
Jan 18How Much Did B.R.A.I.N. Biotechnology Research and Information Network's(ETR:BNN) Shareholders Earn From Share Price Movements Over The Last Three Years?
Dec 31
Are Institutions Heavily Invested In B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shares?
Dec 10Should You Investigate B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) At €7.30?
Nov 17Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if BNN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BNN's dividend payments have been increasing.
Dividend Yield vs Market
| BRAIN Biotech Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (BNN) | n/a |
| Market Bottom 25% (DE) | 1.7% |
| Market Top 25% (DE) | 4.8% |
| Industry Average (Chemicals) | 5.6% |
| Analyst forecast (BNN) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate BNN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BNN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate BNN's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as BNN has not reported any payouts.